688016.SH
Shanghai MicroPort Endovascular MedTech Co., Ltd.
SSE · Healthcare · Medical - Devices · CN
CNY 84.10
−0.36%Year over year
Reported trailing growth
- Revenue
- +17.6%
- EBITDA
- —
- EBIT
- +14.9%
- EPS
- +33.2%
- Free cash flow
- +529.0%
- Operating cash flow
- +169.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.6%
- EBITDA
- +17.7%
- EBIT
- +16.4%
- Net income
- +16.4%
- EPS
- -2.1%
- Free cash flow
- +89.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026